This document provides definitions, guidelines, a framework and a risk-based approach for the design, selection and validation for methods for rapid microbial detection cellular therapeutic product manufacturing.
This document contains the generalized requirements and risks associated with cellular therapeutic product manufacturing, with flexibility to address differences in specific manufacturing processes of each unique cellular therapeutic product.